Correlation Between Johnson Johnson and Iterum Therapeutics
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Iterum Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Iterum Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Iterum Therapeutics PLC, you can compare the effects of market volatilities on Johnson Johnson and Iterum Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Iterum Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Iterum Therapeutics.
Diversification Opportunities for Johnson Johnson and Iterum Therapeutics
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Johnson and Iterum is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Iterum Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iterum Therapeutics PLC and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Iterum Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iterum Therapeutics PLC has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Iterum Therapeutics go up and down completely randomly.
Pair Corralation between Johnson Johnson and Iterum Therapeutics
Considering the 90-day investment horizon Johnson Johnson is expected to generate 34.6 times less return on investment than Iterum Therapeutics. But when comparing it to its historical volatility, Johnson Johnson is 7.02 times less risky than Iterum Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Iterum Therapeutics PLC is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 117.00 in Iterum Therapeutics PLC on August 27, 2024 and sell it today you would earn a total of 64.00 from holding Iterum Therapeutics PLC or generate 54.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Johnson Johnson vs. Iterum Therapeutics PLC
Performance |
| Timeline |
| Johnson Johnson |
| Iterum Therapeutics PLC |
Johnson Johnson and Iterum Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Johnson Johnson and Iterum Therapeutics
The main advantage of trading using opposite Johnson Johnson and Iterum Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Iterum Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iterum Therapeutics will offset losses from the drop in Iterum Therapeutics' long position.| Johnson Johnson vs. Capricor Therapeutics | Johnson Johnson vs. Soleno Therapeutics | Johnson Johnson vs. Bio Path Holdings | Johnson Johnson vs. Moleculin Biotech |
| Iterum Therapeutics vs. Adial Pharmaceuticals | Iterum Therapeutics vs. Tonix Pharmaceuticals Holding | Iterum Therapeutics vs. Fortress Biotech | Iterum Therapeutics vs. Eyenovia |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |